Our full-spectrum CBD-oil concentrates are integrated into the production line of regulatory approved R&D pharmaceutical development partners in Uruguay and Paraguay. Our pharmaceutical partners performs the standardization of the oil concentrates under the high quality associated with GMP medical-grade production benchmarks. Hardolin will subject to the appropriate licenses and export permits being issued, deliver the final standardized product directly to our industrial licensed customers from the production platform of our pharmaceutical partners. This secures a fully compliant GMP setting all the way from farming to end delivery of our crude oils.
Hardolin operates a plantation in Uruguay for the purpose of cultivating Cannabis Sativa plants that allows for a final extraction of high quality full-spectrum Cannabinoid Oil.